Biolex Therapeutics' Growth Equity Round

Biolex Therapeutics raised a round of funding on July 21, 2008.

Biolex Therapeutics is a clinical-stage biopharmaceutical company that uses the LEX System to develop follow-on biologics, hard-to-make therapeutic proteins and monoclonal antibodies that have been op…

Articles about Biolex Therapeutics' Growth Equity Round: